Fred A Middleton
CIK 1267959 · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.20M
Companies
10
Total Filings
129
Lifetime Open-Market Net
-$73.53M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CALC | Director | 983,258 | $0.75 | $735.6K | $2.77M | 9 | 2026-06-29 |
| CHIMERIX INC (CMRX) Delisted | Director | 0 | $8.54 | $0 | $464.2K | 20 | 2025-04-21 |
| CalciMedica, Inc. (SCPH) Delisted | Director | 39,170 | $5.67 | $222.1K | $404.0K | 2 | 2024-11-05 |
| CalciMedica, Inc. (GRAY) Delisted | Director | 17,682 | $5.50 | $97.3K | $0 | 1 | 2023-03-22 |
| ENDOCYTE INC (ECYT) Delisted | Director | 0 | — | — | $5.32M | 16 | 2018-12-21 |
| STXS | Director | 343,244 | $1.34 | $459.9K | $5.97M | 50 | 2018-03-05 |
| Stereotaxis, Inc. (STXS.R) Delisted | Director | — | — | — | $0 | 4 | 2013-11-22 |
| PCRX | Director | 70,399 | $26.48 | $1.86M | -$61.29M | 10 | 2013-06-25 |
| BEAT | Director | 279,237 | $0.51 | $142.1K | -$27.16M | 11 | 2010-05-11 |
| MMRGlobal, Inc. (FVRL) Delisted | Director | 116,678 | — | — | $0 | 2 | 2007-11-06 |
Recent Filings · Page 9 of 13
129 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-12-19 | ENDOCYTE INC (ECYT) Delisted | Buy (P) | +50,000 | $158.0K | EDGAR |
| 2011-11-23 | PCRX | Buy (P) | +10,000 | $65.0K | EDGAR |
| 2011-09-19 | STXS | Buy (P) | +4,850 | $6.7K | EDGAR |
| 2011-09-06 | STXS | Buy (P) | +17,119 | $23.5K | EDGAR |
| 2011-06-15 | STXS | Buy (P) | +10,000 | $30.0K | EDGAR |
| 2011-06-06 | PCRX | Grant (A) | — | $0 | EDGAR |
| 2011-05-31 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-27 | STXS | Grant (A) | +7,200 | $0 | EDGAR |
| 2011-03-09 | ENDOCYTE INC (ECYT) Delisted | Mixed | +1,302,453 | $0 | EDGAR |
| 2011-02-11 | ENDOCYTE INC (ECYT) Delisted | Mixed | +2,217,224 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.